门控首过18F-FDG PET评估左心室功能:与平衡法放射性核素血管造影的验证对比
结果显示伪平面PET射血分数与平面ERNA一致性良好(ccc=0.81),全断层模式测量的左室舒张末期容积、收缩末期容积和射血分数与SPECT ERNA一致(ccc分别为0.83、0.92、0.89),提示该方法或可作为肿瘤患者左室功能评估的替代选择。
要点
- 门控首过18F-FDG PET评估左室射血分数与平面ERNA一致性良好(ccc=0.81)。
- 全断层PET测量的左室容积和射血分数与SPECT ERNA一致(ccc 0.83–0.92)。
- 该方法或可同时评估肿瘤治疗反应和心脏毒性。
核心结论
- 门控首过18F-FDG PET可能作为ERNA评估左室功能的 relevant 替代方法,实现肿瘤患者治疗反应与心脏毒性的联合评估。
研究设计与样本
- 门控动态PET图像在示踪剂首过左室期间重建1分钟,使用自研软件TomPool后处理。
- 伪平面PET图像经阈值区域生长和梯度 delineation 自动分割产生左室射血分数估计;全断层模式产生左室舒张末期容积、收缩末期容积和射血分数估计。
- 一致性采用Lin一致性相关系数(ccc)和Bland-Altman分析评估;可重复性采用变异系数(CoV)和组内相关系数(ICC)评估。
主要发现
- 伪平面PET射血分数与平面ERNA一致(ccc=0.81,P<.001),偏差为0%(95%CI [-2%; 3%],一致性界限[-11%; 12%])。
- PET与ERNA的可重复性均优秀且相似(CoV分别为2±1%和3±2%,P=NS;ICC分别为0.97和0.92)。
- 全断层模式测量的左室舒张末期容积与SPECT ERNA一致(ccc=0.83,偏差=-3 mL)。
- 全断层模式测量的左室收缩末期容积与SPECT ERNA一致(ccc=0.92,偏差=0 mL)。
- 全断层模式测量的左室射血分数与SPECT ERNA一致(ccc=0.89,偏差=-1%),所有ccc的P值<.001,所有偏差均不显著。
临床怎么用
- 对于接受心脏毒性化疗的肿瘤患者,可考虑在18F-FDG PET检查中增加门控首过采集,同步评估左室功能与治疗反应。
- 伪平面和全断层两种后处理模式均可提供与ERNA一致的左室功能参数,可根据临床需要选择。
局限性
- 研究使用自研软件TomPool后处理,外推至其他软件平台需进一步确认。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: We appraised the feasibility of left ventricle (LV) function assessment using gated first-pass 18F-FDG PET, and assessed the concordance of the produced measurements with equilibrium radionuclide angiography (ERNA). MATERIALS AND METHODS: Twenty-four oncologic patients benefited from 99mTc-labeled red-blood-cell ERNA, in planar mode (all patients) and using SPECT (22 patients). All patients underwent gated first-pass 18F-FDG cardiac PET. Gated dynamic PET images were reconstructed over 1 minute during tracer first-pass inside the LV and post-processed using in-house software (TomPool). After re-orientation into cardiac canonical axes and adjustment of the valves plane using a phase image, pseudo-planar PET images obtained by re-projection were automatically segmented using thresholded region growing and gradient-based delineation to produce an LV ejection fraction (EF) estimate. PET images were also post-processed in fully-tomographic mode to produce LV end diastole volume (EDV), end systole volume (ESV), and EF estimates. Concordance was assessed using Lin's concordance (ccc) and Bland-Altman analysis. Reproducibility was assessed using the coefficient of variation (CoV) and intra-class correlation (ICC). RESULTS: Pseudo-planar PET EF estimates were concordant with planar ERNA (ccc = 0.81, P < .001) with a bias of 0% (95% CI [- 2%; 3%], limits of agreement [- 11%; 12%]). Reproducibility was excellent and similar for both methods (CoV = 2 ± 1% and 3 ± 2%, P = NS; ICC = 0.97 and 0.92, for PET and ERNA, respectively). Measurements obtained in fully-tomographic mode were concordant with SPECT ERNA: ccc = 0.83 and bias = - 3 mL for LV EDV, ccc = 0.92 and bias = 0 mL for LV ESV, ccc = 0.89 and bias = - 1% for LV EF (all P values < .001 for ccc, all biases not significant). CONCLUSIONS: Gated first-pass 18F-FDG PET might stand as a relevant alternative to ERNA for LV function assessment, enabling a joint evaluation of both therapeutic response and cardiac toxicity in oncologic patients receiving cardiotoxic chemotherapy.
引用
- Ben Bouallègue F, Maïmoun L, Kucharczak F, et al. Left ventricle function assessment using gated first-pass 18F-FDG PET: Validation against equilibrium radionuclide angiography. J Nucl Cardiol. 2019. PMID: 31044403. doi:10.1007/s12350-019-01731-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。